Bizarre Patents
Reward Candy Dispenser for Personal Computers
A personal computer peripheral, battery powered reward candy dispenser which immediately presents students with a single candy for each problem completed correctly.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8101730 | Method for synthesizing rare-earth oxo isopropoxide Provided is a method for synthesizing a rare-earth oxo isopropoxide safely with a high yield, using a rare-earth metal, which is more inexpensive than anhydrous rare-earth chlorides, as a raw material. In a solvent containing 90% or more by weight of isopropy... | 01/24/2012 |
| 7956168 | Organometallic compounds having sterically hindered amides This invention relates to organometallic compounds represented by the formula M(NR1R2)x wherein M is a metal or metalloid, R1 is the same or different and is a hydrocarbon group or a heteroatom-containing group, R2 | 06/07/2011 |
| 7947814 | Metal complexes of polydentate beta-ketoiminates A plurality of metal-containing complexes of a polydentate beta-ketoiminate, one embodiment of which is represented by the structure are shown: wherein M is a metal such as calcium, strontium, bariu... | 05/24/2011 |
| 7906631 | Method of producing rare earth salt of dialkyl phosphate or dioleyl phosphate There is provided a method of producing a rare earth salt of a dialkyl phosphate or a rare earth salt of dioleyl phosphate of a high purity useful as a polymerization catalyst of a conjugated diene compound by directly reacting a rare earth oxide or a rare earth hyd... | 03/15/2011 |
| 7745590 | Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof Degradable macromolecular magnetic resonance imaging contrast agents for use in various diagnostic procedures, and methods for synthesizing, using and degrading these agents, are described. The macromolecule contrast agents disclosed in various aspects of this inven... | 06/29/2010 |
| 7723493 | Metal complexes of tridentate BETA -ketoiminates Metal-containing complexes of a tridentate beta-ketoiminate, one embodiment of which is represented by the structure: wherein M is a metal such as calcium, strontium, barium, scandium, yttrium, lant... | 05/25/2010 |
| 7718781 | Hydroxypyridonate and hydroxypyrimidinone chelating agents The present invention provides hydroxypyridinone and hydroxypyrimidone chelating agents. Also provides are Gd(III) complexes of these agents, which are useful as contrast enhancing agents for magnetic resonance imaging. The invention also provides methods of prepari... | 05/18/2010 |
| 7696331 | High dose radionuclide complexes for bone marrow treatment The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositi... | 04/13/2010 |
| 7691985 | Skeletal-targeted radiation to treat bone-associated pathologies The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositi... | 04/06/2010 |
| 7691984 | Metal complexes of tridentate β-ketoiminates Metal-containing complexes of a tridentate beta-ketoiminate, one embodiment of which is represented by the structure: wherein M is a metal such as calcium, strontium, barium, scandium, yttrium, lant... | 04/06/2010 |
| 7605239 | Skeletal-targeted radiation to treat bone-associated pathologies The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositi... | 10/20/2009 |
| 7438893 | Polybiotin compounds for magnetic resonance imaging and drug delivery The invention relates generally to biotin-containing compounds that are useful as imaging agents and drug-delivery agents. Another aspect of the invention relates to the aforementioned compounds chelated to a metal atom. In a preferred embodiment, the metal atom is ... | 10/21/2008 |
| 7439338 | Beta-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same The present invention provides metal-containing compounds that include at least one β-diketiminate ligand, and methods of making and using the same. In certain embodiments, the metal-containing compounds include at least one β-diketiminate ligand with at least one... | 10/21/2008 |
| 7429294 | Color compositions The present invention includes a paint or coating composition comprising an organic pigment or dye complexed to the surface of a layered or fibrous inorganic clay. A wide variety of paint colors can be obtained by varying the pH during the preparation as well as by ... | 09/30/2008 |
| 7425235 | Color compositions and methods of manufacture The present invention includes a paint or coating composition comprising an organic pigment or dye complexed to the surface of a layered or fibrous inorganic clay. A wide variety of paint colors can be obtained by varying the pH during the preparation as well as by ... | 09/16/2008 |
| 7408046 | Treatment of bone-associated cancers The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositi... | 08/05/2008 |
| 7399460 | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications Diagnostic and therapeutic compositions in the form of complexes for enhancing transmembrane transport of a diagnostic or therapeutic agent and methods for their use. The complexes contain the α, γ, or bis isomers of folate receptor-binding analogs of folate, a me... | 07/15/2008 |
| 7390861 | Cationic group-3 catalyst system A cationic Group 3 or Lanthanide metal complex for coordination polymerization of olefins is disclosed. The precursor metal complex is stabilized by an anionic multidentate ancillary ligand and two monoanionic ligands. The ancillary ligand and the transition metal f... | 06/24/2008 |
| 7388082 | Alkoxyalcohol adduct of rare earth monocarboxylate An alkoxyalcohol adduct of rare earth monocarboxylate has the formula (I): M(R2—COO)3.(R1O(CH2)nOH)p (I) in which M is a rare earth element such as Pr, Nd, Pm, Sm, Eu, Gd,... | 06/17/2008 |
| 7378077 | High dose radionuclide complexes for bone marrow suppression The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositi... | 05/27/2008 |
| 7371742 | Porphyrin derivatives for photodynamic therapy This invention relates to porphyrin compounds used to destroy or impair the functioning of a target biological material in photodynamic therapy, in particular against virus, tumoral cells, bacteria, tumorous tissues. The invention also relates to compositions contai... | 05/13/2008 |
| 7358380 | Ru-substituted polyoxometalates and process for their preparation The invention relates to polyoxometalates represented by the formula (An)m+[R2(H2O)6X2W20O70]m− or solvates thereof, wherein A represents a cation, n is the number o... | 04/15/2008 |
| 7358343 | Endohedral metallofullerene derivatives Trimetallic nitride endohedral metallofullerene derivatives and their preparation are described. The trimetallic nitride endohedral metallofullerene derivatives have the general formula A3-nXn@Cm(R) where n ranges from 0 to 3, A and ... | 04/15/2008 |
| 7344698 | Integrin targeted imaging agents Emulsions preferably of nanoparticles formed from high boiling liquid perfluorochemical substances, said particles coated with a lipid/surfactant coating are made specific to regions of activated endothelial cells by coupling said nanoparticles to a ligand specific ... | 03/18/2008 |
| 7342078 | Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins A process for the polymerization of olefins, in particular a process for the copolymerization of propylene with further olefins, is carried out in the presence of highly active catalyst systems comprising specifically selected metallocenes, in particular ones which ... | 03/11/2008 |
| 7323581 | Source reagent compositions and method for forming metal films on a substrate by chemical vapor deposition A metalorganic complex composition comprising a metalorganic complex selected from the group consisting of: metalorganic complexes comprising one or more metal central atoms coordinated to one or more monodentate or multidentate organic ligands, and complexed with o... | 01/29/2008 |
| 7321027 | Small technetium-99m and rhenium labeled agents and methods for imaging tumors The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods o... | 01/22/2008 |
| 7321045 | Vitronectin receptor antagonist pharmaceuticals The present invention describes novel compounds of the formula: (Q)d-Ln-Ch, useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of treating cancer in a patient. Th... | 01/22/2008 |
| 7314582 | Lanthanide-halide based humidity indicators The present invention discloses a lanthanide-halide based humidity indicator and method of producing such indicator. The color of the present invention indicates the humidity of an atmosphere to which it is exposed. For example, impregnating an adsorbent support suc... | 01/01/2008 |
| 7312251 | Synthesis of stable solutions of rare earth tris (organophosphate) in hydrocarbon solvents Stable rare earth tris (organophosphate) solutions comprise a rare earth tris (organophosphate) and a hydrocarbon solvent. From about 2% to about 10% rare earth element, preferably from about 3% to about 8%, is present in the solutions. The rare earth tris (organoph... | 12/25/2007 |
| 7309567 | Method for reducing fluorescence quenching in bioassays The invention relates to a process for reducing the fluorescence quenching caused by the measuring medium, in a fluorescence assay for an analyte using at least one fluorescent label, characterized in that a fluorescent conjugate comprising an oligonucleotide bonded... | 12/18/2007 |
| 7303824 | Electroluminescent device An electroluminescent device which has an electroluminescent layer formed of a binuclear, trinuclear or polynuclear rare earth organic complex in which the metals are linked through a bridging ligand. ... | 12/04/2007 |
| 7294730 | Colorant compounds Disclosed are colorant compounds of the formulae wherein R1, R2, R3, M, A, E, G, J, m, n, and p are as defined herein. ... | 11/13/2007 |
| 7291405 | Organic electroluminescent device An organic electroluminescent device comprising: a pair of electrodes; and at least one organic compound layer between the pair of electrodes, the at least one organic compound layer including a light emitting layer, wherein the light emitting layer contains at leas... | 11/06/2007 |
| 7291516 | Low temperature melt-processing of organic-inorganic hybrid The present invention provides a process for preparing a melt-processed organic-inorganic hybrid material including the steps of maintaining a solid organic-inorganic hybrid material at a temperature above the melting point but below the decomposition temperature of... | 11/06/2007 |
| 7285608 | Metallocene ligands, metallocene compounds and metallocene catalysts, their synthesis and their use for the polymerization of olefins A catalyst system includes a metallocene compound having the formula R9 L1 L2 M1 R1 R2 wherein R9 is a bridge between ligands L1 and L2 and M1 is a metal of... | 10/23/2007 |
| 7279234 | Methods for identity verification using transparent luminescent polymers Disclosed are methods of using a transparent, luminescent polymer for transparent marking and/or labeling for identity verification purposes. Also disclosed are sheets, films, markers, labels and taggants comprising transparent, luminescent polymers. Also disclosed ... | 10/09/2007 |
| 7276494 | Photosensitisers A compound for use as a photosensitiser in PDT, in photochemical internalisation in the production of a cancer vaccine or in the diagnosis or detection of medical conditions, the compound having a photosensitising chromophoric system, a sulphonamido functionality an... | 10/02/2007 |
| 7268220 | Bridged aromatic substituted amine ligands with donor atoms The present invention provides for substituted metal chelating compounds in which at least two of the chelating atoms are nitrogen which are directly attached to aromatic rings and one or more of those nitrogen atoms has attached thereto a substituent other than hyd... | 09/11/2007 |
| 7267990 | Chelation of charged and uncharged molecules with porphyrin-based compounds Porphyrins containing one or more neutral or negatively-charged, closo- or nido-carborane substituents are useful as chelators. The carbon-carbon bonds linking the boron-containing groups to the porphyrin ring make the compounds highly resistant to hydrolysis. These... | 09/11/2007 |
